Literature DB >> 10825687

Superoxide dismutase activity and zinc and copper concentrations in Parkinson's disease.

.   

Abstract

Although several hypotheses are currently being investigated the cause of Parkinson's disease (PD) is still unknown. The aim of this study was to determine red cell copper/zinc-superoxide dismutase (Cu/Zn-SOD) activity and copper and zinc concentrations both in plasma and in red cell in PD. In this preliminary assay, 30 patients with PD the mean age of 64 were studied. Additionally, a second group of older individuals without PD mean age of 61, were recruited to the study. The patient group was compared with the other group according to their red cell Cu/Zn-SOD activities, and plasma and red cell copper, zinc concentrations. Red cell Cu/Zn-SOD activity was measured spectrophotometrically while plasma and red cell copper, zinc concentrations were determined by atomic absorption spectrophotometer. The results were analysed by 'Student t-test' statistically. The results showed that red cell Cu/Zn-SOD activities and red cell copper and zinc and also plasma copper concentrations of the PD patients increased compared to older individuals without PD. These findings suggested that possibility of oxidative stress in PD was reflected on the blood including the red cell and plasma parameters.

Entities:  

Year:  2000        PMID: 10825687     DOI: 10.1016/s0928-4680(00)00030-4

Source DB:  PubMed          Journal:  Pathophysiology        ISSN: 0928-4680


  12 in total

1.  Dipeptide-based models of nickel superoxide dismutase: solvent effects highlight a critical role to Ni-S bonding and active site stabilization.

Authors:  Eric M Gale; Darin M Cowart; Robert A Scott; Todd C Harrop
Journal:  Inorg Chem       Date:  2011-09-20       Impact factor: 5.165

Review 2.  Synthetic analogues of cysteinate-ligated non-heme iron and non-corrinoid cobalt enzymes.

Authors:  Julie A Kovacs
Journal:  Chem Rev       Date:  2004-02       Impact factor: 60.622

3.  Accessing Ni(III)-thiolate versus Ni(II)-thiyl bonding in a family of Ni-N2S2 synthetic models of NiSOD.

Authors:  Ellen P Broering; Stephanie Dillon; Eric M Gale; Ramsey A Steiner; Joshua Telser; Thomas C Brunold; Todd C Harrop
Journal:  Inorg Chem       Date:  2015-04-02       Impact factor: 5.165

4.  Oxidative stress and 17-alpha- and 17-beta-estradiol modulate neurofilaments differently.

Authors:  Keith Chiasson; Vicky Lahaie-Collins; Julie Bournival; Benoit Delapierre; Sylvie Gélinas; Maria-Grazia Martinoli
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 5.  Targeting urate to reduce oxidative stress in Parkinson disease.

Authors:  Grace F Crotty; Alberto Ascherio; Michael A Schwarzschild
Journal:  Exp Neurol       Date:  2017-06-13       Impact factor: 5.330

6.  Superoxide Oxidation by a Thiolate-Ligated Iron Complex and Anion Inhibition.

Authors:  Maksym A Dedushko; Jessica H Pikul; Julie A Kovacs
Journal:  Inorg Chem       Date:  2021-04-26       Impact factor: 5.165

7.  Study of telomere length and different markers of oxidative stress in patients with Parkinson's disease.

Authors:  G Watfa; C Dragonas; T Brosche; R Dittrich; C C Sieber; C Alecu; A Benetos; R Nzietchueng
Journal:  J Nutr Health Aging       Date:  2011-04       Impact factor: 4.075

8.  A functional model for the cysteinate-ligated non-heme iron enzyme superoxide reductase (SOR).

Authors:  Terutaka Kitagawa; Abhishek Dey; Priscilla Lugo-Mas; Jason B Benedict; Werner Kaminsky; Edward Solomon; Julie A Kovacs
Journal:  J Am Chem Soc       Date:  2006-11-15       Impact factor: 15.419

9.  Carbonic anhydrase I, II, and VI, blood plasma, erythrocyte and saliva zinc and copper increase after repetitive transcranial magnetic stimulation.

Authors:  Robert I Henkin; Samuel J Potolicchio; Lucien M Levy; Ramy Moharram; Irina Velicu; Brian M Martin
Journal:  Am J Med Sci       Date:  2010-03       Impact factor: 2.378

Review 10.  Synaptic Zinc: An Emerging Player in Parkinson's Disease.

Authors:  Joanna Sikora; Abdel-Mouttalib Ouagazzal
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.